Alpha Advisors’s Merck MRK Stock Holding History

Alpha Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,312	Closed	-$297K	–	44
2025 Q1	$297K	Sell	3,312 -78	-2%	-$7.28K	0.26%	28
2024 Q4	$337K	Buy	+3,390	New	+$349K	0.35%	28

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Alpha Advisors's MRK Position: Q2 2025 in Review

Alpha Advisors sold out of Merck (MRK) in Q2 2025, closing a stake of 3,312 shares — an estimated $297K sold.

Alpha Advisors first reported a position in MRK in Q4 2024 and held it in 2 quarters. The position peaked at $337K in Q4 2024. 3,332 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

Alpha Advisors reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
Alpha Advisors sold 3,312 Merck shares in Q2 2025, an estimated $297K.
Alpha Advisors first reported a position in Merck in Q4 2024 and held it in 2 quarters.
Alpha Advisors's Merck position peaked at $337K in Q4 2024.
3,332 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Alpha Advisors's 13F filing for Q2 2025, filed 12 Nov 2025.